Page last updated: 2024-10-16

5-hydroxytryptophan and Colonic Neoplasms

5-hydroxytryptophan has been researched along with Colonic Neoplasms in 1 studies

5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.

Colonic Neoplasms: Tumors or cancer of the COLON.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsui, K1
Fukuoka, M1
Takada, M1
Kusunoki, Y1
Yana, T1
Tamura, K1
Yoshida, T1
Iida, K1
Hirashima, T1
Tsukada, H1
Ushijima, S1
Miyawaki, H1
Masuda, N1

Trials

1 trial available for 5-hydroxytryptophan and Colonic Neoplasms

ArticleYear
Randomised trial for the prevention of delayed emesis in patients receiving high-dose cisplatin.
    British journal of cancer, 1996, Volume: 73, Issue:2

    Topics: 5-Hydroxytryptophan; Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Agents; Carcinom

1996